Oral GLP-1 therapies are frequently associated with gastrointestinal side effects, including nausea, diarrhea, constipation, and vomiting
A significant gray zone exists between 200 and 300 pg/mL where patients may experience symptoms despite levels that appear technically normal
In August 2023, Jaclyn Bjorklund from Louisiana filed a lawsuit claiming that her use of Ozempic and Mounjaro led to severe gastrointestinal problems
When it was first identified as part of a bigger protein in the digestive system, researchers were curious about how it behaved in different tissues, including muscle, tendons, ligaments, nerves, and gut tissue
The initial proof-of-concept analysis focused on a group of participants between 12 and 35 years old